Cardiac Wire #280 June 16, 2025
Abelacimab’s Safety, CABG + Ablation, and UK TAVR Troubles
Cardiac Wire #279 June 12, 2025
BP Triple Polypill, Robot TAVR Explant, and Polymer MV
Cardiac Wire #278 June 9, 2025
Decreasing PCI Contrast, ECG for AS, and The Cost of HF
Cardiac Wire #277 June 5, 2025
Regeneron Buys GLP-1, Titanium Hearts, and Breastfeeding vs. ASCVD
Cardiac Wire #276 June 2, 2025
The ABYSS Answers, PPMI Risks, and RNAi for Lp(a)
Cardiac Wire #275 May 29, 2025
BSCI Quits TAVR, a Major PE CV Acquisition, and Mayo + Corify
Cardiac Wire #274 May 22, 2025
Navitor vs. Sapien, Regeneron Wins Lawsuit, and Expensive GLP-1s
Cardiac Wire #273 May 19, 2025
Wegovy’s Quick CV Impact, HF Iron Man, and BP Pills in Bed
Cardiac Wire #272 May 15, 2025
Tirzepatide Triumphs, Killer Foods, and MAPLE-HCM’s Results
Cardiac Wire #271 May 12, 2025
New ASCVD Biomarker, BATMAN, and AI Predicts LBBB
Cardiac Wire #270 May 8, 2025
Obicetrapib’s Results Show, MAR001 Progresses, and Fibrosis Genes
Cardiac Wire #269 May 5, 2025
TAVR for Asymptomatic AS, PFA’s Risks, and CVS + Wegovy
Cardiac Wire #268 May 1, 2025
HRS’ Top Six, CVD X-rays, and OmniaSecure’s Approval
Cardiac Wire #267 April 28, 2025
GLP-1s Impact AF, Kardium’s PFA Shines, and AccurKardia + HeartBeam
Cardiac Wire #266 April 24, 2025
RESILIA Results, Lilly’s Oral GLP-1, and Surmodics’ SurVeil
Cardiac Wire #265 April 21, 2025
AI Strengthens ECG + Echo, Cardiology Salary Dip, and WiSE’s FDA Approval
Cardiac Wire #264 April 17, 2025
VERVE-102’s Validation, Pfizer Ditches GLP-1, and Safer IVC Monitors
Cardiac Wire #263 April 14, 2025
Stopping PSVT, Starfish Monitors, and Post-TAVR Pacemakers
Cardiac Wire #262 April 10, 2025
